医学
危险系数
内科学
可归因风险
置信区间
队列
死因
人口
队列研究
射血分数
心力衰竭
冲程(发动机)
心脏病学
比例危险模型
疾病
流行病学
环境卫生
机械工程
工程类
作者
Daisuke Sugiyama,Tomonori Okamura,Makoto Watanabe,Aya Higashiyama,Nagako Okuda,Yasuyuki Nakamura,Atsushi Hozawa,Yoshikuni Kita,Aya Kadota,Yoshitaka Murakami,Naomi Miyamatsu,Takayoshi Ohkubo,Takehito Hayakawa,Yoshihiro Miyamoto,Katsuyuki Miura,Akira Okayama,Hirotsugu Ueshima
摘要
Aims: The population-attributable fraction (PAF) is an indicator of the disease burden. In Western countries, the PAF of hypercholesterolemia in cardiovascular disease (CVD) is the highest among that for traditional risk factors; however, data for Asian populations are limited. Methods: A 24-year cohort study was conducted among 9,209 randomly selected participants who were not taking statins. We estimated the hazard ratio (HR) after adjusting for covariates and PAF associated with the serum total cholesterol (TC) levels in relation to CVD mortality. Results: The TC level was found to be positively associated with an increased risk of CVD, coronary heart disease (CHD) and cardiac death (CHD plus heart failure), with an HR of 1.08 (95% confidence interval [CI]: 1.00-1.16), 1.33 (95% CI: 1.14-1.55) and 1.21 (95% CI: 1.08-1.35) for a 1-SD increment in the serum TC level, respectively. Similar positive associations between the TC level and both CHD and cardiac death were observed after classifying the patients by age and sex. Furthermore, the highest serum TC level (≥6.72 mmol/L) was positively associated with CVD death, with an HR of 1.76 (95% CI: 1.25-2.47), as well as both CHD death and cardiac death. In contrast, no significant relationships were observed between the serum TC level and stroke. Meanwhile, the PAF for CVD, CHD, and cardiac deaths due to hypercholesterolemia (serum TC level ≥5.69 mmol/L, defined by the Japan Atherosclerosis Society) was 1.7%, 10.6% and 5.6%, respectively. Conclusions: The estimated PAF of CVD death due to hypercholesterolemia is moderately high, but lower than that for other risk factors, such as hypertension.
科研通智能强力驱动
Strongly Powered by AbleSci AI